Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites
Felix Meier‐Stephenson, Vanessa Meier‐Stephenson, Michael D. Carter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification
Chunsheng Lin, Qianqian Tian, Sifan Guo, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2198-2198
Open Access | Times Cited: 16
Sex and Gender Differences in Neurodegenerative Diseases: Challenges for Therapeutic Opportunities
Annalisa Bianco, Ylenia Antonacci, Maria Liguori
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6354-6354
Open Access | Times Cited: 35
The Role of Tryptophan Metabolism in Alzheimer’s Disease
Karl Savonije, Donald F. Weaver
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 292-292
Open Access | Times Cited: 32
Promoting Alzheimer’s disease research and therapy with stem cell technology
Zimeng Cao, Fanshu Kong, Jiaqi Ding, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Tryptophan Metabolism in Alzheimer’s Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis
Lushuang Xie, Qiaofeng Wu, Kelin Li, et al.
Aging and Disease (2024) Vol. 15, Iss. 5, pp. 2168-2168
Open Access | Times Cited: 10
Alzheimer's disease as an innate autoimmune disease (AD2): A new molecular paradigm
Donald F. Weaver
Alzheimer s & Dementia (2022) Vol. 19, Iss. 3, pp. 1086-1098
Open Access | Times Cited: 29
Metabolic imbalance driving immune cell phenotype switching in autoimmune disorders: Tipping the balance of T‐ and B‐cell interactions
Matteo Barberis, Alejandra Rojas López
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 7
Regulated Arginine Metabolism in Immunopathogenesis of a Wide Range of Diseases: Is There a Way to Pass between Scylla and Charybdis?
Э. А. Старикова, Artem Rubinstein, J. T. Mammedova, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3525-3551
Open Access | Times Cited: 14
Molecular mechanisms implicated in protein changes in the Alzheimer’s disease human hippocampus
Hai Duc Nguyen, Woong-Ki Kim, Giang Huong Vu
Mechanisms of Ageing and Development (2024) Vol. 219, pp. 111930-111930
Open Access | Times Cited: 5
Exploring the molecular characterization of PANoptosis-related genes with features of immune dysregulation in Alzheimer’s disease based on bulk and single-nuclei RNA sequencing
Hanjie Liu, Maochun You, Hui Yang, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
Zarah R. Haniff, Mariia Bocharova, Tim Mantingh, et al.
Pharmacology & Therapeutics (2024) Vol. 258, pp. 108641-108641
Open Access | Times Cited: 4
Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights
Junyi Liang, Wang Yueyang, Bin Liu, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 4
Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer’s Disease
Zhiwu Dong, Hongjun Gu, Qiang Guo, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3830-3830
Open Access | Times Cited: 17
Paraoxonases at the Heart of Neurological Disorders
Fatimah K. Khalaf, Jacob Connolly, Bella Khatib-Shahidi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6881-6881
Open Access | Times Cited: 9
Alcohol extract of Rubia yunnanensis: Metabolic alterations and preventive effects against OGD/R‑induced oxidative damage in HT22 cells
Jianghao Cheng, Gaoyizhou Li, Liping Yang, et al.
Biomedical Reports (2024) Vol. 20, Iss. 5
Open Access | Times Cited: 3
Targeting Caspases 3/6 and Cathepsins L/B May Decrease Laminopathy-Induced Apoptosis in Alzheimer’s Disease
Auob Rustamzadeh, Abbas Tafakhori, Armin Ariaei, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. 1, pp. 211-221
Closed Access | Times Cited: 3
Microvascular and cellular dysfunctions in Alzheimer’s disease: an integrative analysis perspective
Mengjie Li, Xiaoyan Hao, Zhengwei Hu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Association of immune-mediated diseases with the risk of dementia and brain structure in UK Biobank participants
Jinhua Cai, Heng Rong, Jiongxue Chen, et al.
Age and Ageing (2024) Vol. 53, Iss. 12
Closed Access | Times Cited: 3
Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression
Karl Savonije, Autumn Meek, Donald F. Weaver
Brain Sciences (2023) Vol. 13, Iss. 6, pp. 852-852
Open Access | Times Cited: 8
Exploring the impact of miR-128 in inflammatory diseases: A comprehensive study on autoimmune diseases
Ria Margiana, Hamzah H. Kzar, Fadhil Hussam, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154705-154705
Open Access | Times Cited: 8
Microbiome Alterations and Alzheimer’s Disease: Modeling Strategies with Transgenic Mice
Juan Antonio López-Villodres, Alejandro Escamilla, Silvia Mercado-Sáenz, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1846-1846
Open Access | Times Cited: 7
Towards early diagnosis of Alzheimer’s disease: advances in immune-related blood biomarkers and computational approaches
Sophia Krix, Ella Wilczynski, Neus Falgàs, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Endogenous Antimicrobial‐Immunomodulatory Molecules: Networking Biomolecules of Innate Immunity
Donald F. Weaver
ChemBioChem (2024) Vol. 25, Iss. 12
Closed Access | Times Cited: 2
Targeting Microglial Immunoproteasome: A Novel Approach in Neuroinflammatory-Related Disorders
Natalia Małek, Radoslaw Gladysz, Natalia Stelmach, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 14, pp. 2532-2544
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top